Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aristopet pty ltd - methylene blue - misc. fish tank medication - methylene blue dye-blue active 12.0 mg/ml - parasiticides - fish aquarium freshwater | fish egg | cold water | tropical - fungal infection | white spot | whitespot

United States - English - NLM (National Library of Medicine)

method pharmaceuticals, llc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, anhydrous (unii: kh7i04hpuu) (sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - methenamine 81 mg - uro-458 tablets is indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. uro-458 tablets is contraindicated in patients with a hypersensitivity to any of the ingredients. risk-benefit should be considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).

United States - English - NLM (National Library of Medicine)

biocomp pharma, inc. - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), benzoic acid (unii: 8skn0b0mim) (benzoic acid - unii:8skn0b0mim), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - hyophen ® tablets are indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. hypersensitivity to any of the ingredients is possible. risk benefits should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis, acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy). a dependence on the use of hyophen ® tablets has not been reported and due to the nature of its ingredients, abuse of hyophen ® tablets is not expected.

Malta - English - Medicines Authority

macarthys laboratories limited bampton road, harold hill, romford essex, rm3 8ug, united kingdom - methylene blue - solution for injection - methylene blue 1 % (w/v) - all other therapeutic products

Canada - English - Health Canada

phebra pty ltd - methylene blue - solution - 10mg - methylene blue 10mg - antidotes

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - methylene blue (unii: t42p99266k) (methylene blue - unii:t42p99266k) -

United States - English - NLM (National Library of Medicine)

cameron pharmaceuticals - methylene blue anhydrous (unii: 8nap7826ub) (methylene blue cation - unii:zmz79891zh) - drug-induced methemoglobinemia. methylene blue can cause fetal harm when administered to a pregnant woman. an association exists between the use of methylene blue in amniocentesis and atresia of the ileum and jejunum, ileal occlusions, and other adverse effects in the neonate. (2, 3) methylene blue is contraindicated in women who are or may become pregnant. if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. intraspinal and subcutaneous injections are contraindicated. methylene blue is contraindicated in patients with a known hypersensitivity to the drug.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

qpharma pty ltd - acriflavine; methylene blue dye; malachite green - misc. fish tank medication - acriflavine anilide/aniline active 2.0 mg/ml; methylene blue dye dye-blue active 4.0 mg/ml; malachite green dye-green active 0.4 mg/ml - antibiotic & related - fish aquarium | ornamental fish | ornamental fish pond | tropical fish - general fungal disease | velvet disease | white spot | oodinium limneticum | oodinium pillularis | whitespot

Canada - English - Health Canada

hikma canada limited - methylene blue - solution - 10mg - methylene blue 10mg - antidotes

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

australian pet supplies pty ltd - methylene blue; acriflavine; malachite green - misc. fish tank medication - methylene blue dye-blue active 4.0 mg/ml; acriflavine anilide/aniline active 2.0 mg/ml; malachite green dye-green active 0.4 mg/ml - parasiticides - fish aquarium freshwater | cold water | tropical - fin and tail rot | general fungal disease | velvet disease | white spot | fin rot | oodinium limneticum | oodinium pillularis | tail rot | whitespot